Poly Medicure has approved the acquisition of Citieffe Group, a Swiss corporation along with its subsidiaries in Italy, the USA, and Mexico, through its wholly-owned subsidiary, Poly Medicure B.V. Following the acquisition, Poly Medicure B.V. will own 100% stake in the Citieffe Group. Also, the company allotted 33,775 equity shares to eligible employees under its stock option scheme.
Citieffe Group Acquisition
Poly Medicure’s board has approved the acquisition of Medistream SA, a Swiss Corporation, along with its wholly-owned subsidiaries, Citieffe SRL (Italy), Citieffe Inc. (USA), and Citieffe De (Mexico), collectively known as the “Citieffe Group”. This acquisition will be executed through Poly Medicure’s wholly-owned subsidiary, Poly Medicure B.V., Amsterdam.
Ownership Structure
Upon completion of the acquisition, Poly Medicure Limited, via Poly Medicure B.V., will gain 100% ownership of the Citieffe Group. The decision was made during a board meeting on September 24, 2025.
Employee Stock Option Allotment
In addition to the acquisition, the board also approved the allotment of 33,775 equity shares to eligible employees under the Employee Stock Option Scheme, 2020. Each share has a face value of Rs. 5.
Updated Equity Share Capital
Following the allotment, the paid-up Equity Share Capital of Poly Medicure has increased to Rs. 50,67,97,450, consisting of 10,13,59,490 equity shares with a face value of Rs. 5 each. This is an increase from the previous capital of Rs. 50,66,28,575, which consisted of 10,13,25,715 equity shares.
Source: BSE
